These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36690299)

  • 1. Efficacy of long-term pituitary down-regulation pretreatment prior to in vitro fertilization in infertile patients with endometriosis: A meta-analysis.
    Tian Y; Zhang L; Qi D; Yan L; Song J; Du Y
    J Gynecol Obstet Hum Reprod; 2023 Mar; 52(3):102541. PubMed ID: 36690299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.
    Georgiou EX; Melo P; Baker PE; Sallam HN; Arici A; Garcia-Velasco JA; Abou-Setta AM; Becker C; Granne IE
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31747470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of different down-regulating protocols on in vitro fertilization-embryo transfer in endometriosis: a meta-analysis.
    Cao X; Chang HY; Xu JY; Zheng Y; Xiang YG; Xiao B; Geng XJ; Ni LL; Chu XY; Tao SB; He Y; Mao GH
    Reprod Biol Endocrinol; 2020 Feb; 18(1):16. PubMed ID: 32113479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of ultra-long protocol on in vitro fertilization/intracytoplasmic sperm injection-embryo transfer outcome in infertile women with endometriosis: A systematic review and meta-analysis of randomized controlled trials.
    Liu S; Xie Y; Li F; Jin L
    J Obstet Gynaecol Res; 2021 Apr; 47(4):1232-1242. PubMed ID: 33432620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis.
    Sallam HN; Garcia-Velasco JA; Dias S; Arici A
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004635. PubMed ID: 16437491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation.
    van der Houwen LE; Mijatovic V; Leemhuis E; Schats R; Heymans MW; Lambalk CB; Hompes PG
    Reprod Biomed Online; 2014 Jan; 28(1):39-46. PubMed ID: 24262434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
    Kadoura S; Alhalabi M; Nattouf AH
    Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
    Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis.
    Zhang L; Cai H; Liu X; Xiong Y; Liang X; Shi J
    BMC Pregnancy Childbirth; 2022 Dec; 22(1):946. PubMed ID: 36528566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.
    Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study.
    Chen M; Luo L; Wang Q; Gao J; Chen Y; Zhang Y; Zhou C
    Front Endocrinol (Lausanne); 2020; 11():318. PubMed ID: 32547490
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of In Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Among Patients with Endometriosis After a Shortened Protocol of Long-Term Pituitary Downregulation.
    Kong H; Bu Z; Guo Y; Wang F; Shi H; Hu L; Sun Y
    Med Sci Monit; 2019 Jun; 25():4377-4383. PubMed ID: 31187785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI.
    Mijatovic V; Florijn E; Halim N; Schats R; Hompes P
    Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):62-5. PubMed ID: 20409633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ultra-long study: a randomized controlled trial evaluating long-term GnRH downregulation prior to ART in women with endometriosis.
    Tomassetti C; Beukeleirs T; Conforti A; Debrock S; Peeraer K; Meuleman C; D'Hooghe T
    Hum Reprod; 2021 Sep; 36(10):2676-2686. PubMed ID: 34370858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Gonadotrophin-Releasing Hormone Agonist Addition for Luteal Support on Pregnancy Outcome in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-Analysis Based on Randomized Controlled Trials.
    Ma X; Du W; Hu J; Yang Y; Zhang X
    Gynecol Obstet Invest; 2020; 85(1):13-25. PubMed ID: 31422404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
    Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study.
    Lan J; Wu Y; Wu Z; Wu Y; Yang R; Liu Y; Lin H; Jiao X; Zhang Q
    Front Endocrinol (Lausanne); 2021; 12():609771. PubMed ID: 34135858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.